R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Associate Director - Global Revenue, Technical Accounting & Reporting

Financial AccountingConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree in Accounting, Finance, or a related field is required.
  • At least 10 years of progressive accounting experience, including revenue accounting and technical accounting experience in the pharmaceutical industry.
  • Deep knowledge of U.S. generally accepted accounting principles, with strong expertise in ASC 606 revenue recognition.
  • Strong experience reviewing revenue contracts and preparing technical accounting memoranda.
  • Global revenue accounting experience.
  • Experience preparing revenue SEC disclosures.
  • Strong SOX, internal controls, and audit experience.
  • Experience working across global Finance and Accounting teams.
  • Strong analytical, problem-solving, and communication skills.

Responsibilities

  • Own the development, maintenance, and application of global revenue accounting policies and procedures, ensuring alignment with U.S. GAAP and SEC reporting requirements and the company’s evolving commercial operations.
  • Lead technical accounting assessments for complex revenue and contra-revenue arrangements across U.S. and international markets. Partner with regional Finance and Accounting teams to review commercial contracts, evaluate country-specific arrangements, determine appropriate accounting treatment, and ensure consistent application of global revenue policies.
  • Prepare technical accounting memoranda documenting key contractual terms, significant judgments, accounting conclusions, and required treatment under U.S. GAAP. Partner with external auditors on accounting matters as needed.
  • Own the monthly close for gross revenue and accounts receivable, including journal entries, reconciliations, and supporting analyses. Oversee the order-to-cash process performed by the third-party logistics provider, review accounts receivable activity and aging, and resolve accounting or operational issues with internal and external partners.
  • Guide U.S. and international Finance and Accounting teams in consistently applying global revenue accounting policies and technical accounting conclusions, translating accounting guidance into practical processes, controls, and reporting requirements.
  • Own the preparation and coordination of revenue SEC disclosures and supporting schedules, working with the SEC Reporting team to provide required analyses, technical accounting support, and disclosure inputs. Gather and review inputs from the gross-to-net team, regional Finance teams, and other stakeholders, and reconcile disclosures to reported financial results.
  • Establish, maintain, and improve SOX controls over global revenue and order-to-cash processes. Partner with Internal Audit and external auditors on control design, testing, audit requirements, and remediation of identified issues.
  • Lead revenue accounting audit support, including preparing supporting documentation, communicating technical accounting conclusions, coordinating auditor requests, and resolving accounting and control matters with relevant stakeholders.
  • Own end-to-end accounting and reporting for royalty arrangements, including interpreting contractual terms, royalty calculations, journal entries, reconciliations, settlements, and coordination with internal and external partners.
  • Own accounting for the international pharmacy program, including revenue recognition and financial reporting. Serve as the primary Finance and Accounting contact for the program and manage the partner relationship from a Finance perspective.

Desired Qualifications

  • CPA.
  • Public accounting experience.
  • Experience supporting a first product launch or an early-commercial-stage biotechnology company.
  • Experience with royalty accounting and reporting.
  • Experience using artificial intelligence tools and automation to improve journal entries, close reporting, documentation, and other accounting processes.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs